Standard Biotools (LAB) Total Current Liabilities (2010 - 2026)
Standard Biotools (LAB) posted quarterly Total Current Liabilities of $42.2 million for Q1 2026, down 24.95% year-over-year from $56.2 million in Q1 2025, and down 61.03% quarter-over-quarter from $108.3 million in Q4 2025.
Standard Biotools (LAB) Total Current Liabilities (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Total Current Liabilities for 17 consecutive years, with $42.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 24.95% year-over-year to $42.2 million; the TTM figure through Mar 2026 stood at $42.2 million (down 24.95% YoY), while the FY2025 annual figure was $108.3 million, up 64.36% from the prior year.
- Total Current Liabilities retreated to $42.2 million in Q1 2026 per LAB's latest filing, from $108.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $123.8 million in Q2 2024 and bottomed at $42.2 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $75.1 million across 5 years, with a median of $56.2 million in 2025.
- Annual changes were most pronounced in 2024 — Total Current Liabilities soared 177.6% — and 2025, when it sank 53.74%.
- Standard Biotools' Total Current Liabilities stood at $43.4 million in 2022, then surged by 151.66% to $109.3 million in 2023, then tumbled by 39.73% to $65.9 million in 2024, then jumped by 64.36% to $108.3 million in 2025, then slumped by 61.03% to $42.2 million in 2026.
- Business Quant data shows LAB's Total Current Liabilities at $42.2 million in Q1 2026, $108.3 million in Q4 2025, and $108.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 127.31 Bn | 123.83 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.93 Bn | 109.71 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.35 Bn | 72.82 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Standard Biotools | 252.86 Mn | -223.86 Mn | 10.54 Mn | 56.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.80 Mn |
| Mar 31, 2026 | 42.20 Mn |
| Dec 31, 2025 | 108.31 Mn |
| Sep 30, 2025 | 107.97 Mn |
| Jun 30, 2025 | 98.02 Mn |
| Mar 31, 2025 | 56.24 Mn |
| Dec 31, 2024 | 65.90 Mn |
| Sep 30, 2024 | 120.62 Mn |
| Jun 30, 2024 | 123.81 Mn |
| Mar 31, 2024 | 121.55 Mn |
| Dec 31, 2023 | 109.33 Mn |
| Sep 30, 2023 | 51.80 Mn |
| Jun 30, 2023 | 46.84 Mn |
| Mar 31, 2023 | 43.79 Mn |
| Dec 31, 2022 | 43.44 Mn |
| Sep 30, 2022 | 46.17 Mn |
| Jun 30, 2022 | 42.77 Mn |
| Mar 31, 2022 | 47.17 Mn |
| Dec 31, 2021 | 49.57 Mn |
| Sep 30, 2021 | 47.29 Mn |